Dr. Wachman received her MD from the BU School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal abstinence syndrome (NAS) quality improvement and research at BMC. Her research primarily focuses on examining genetic and epigenetic predictors of NAS outcomes. She is a site Co-Investigator of a NIDA clinical trial exploring optimal treatment options for NAS, as well as genetic variations and developmental outcomes in these high-risk infants. Her other primary research interests include the care of premature infants with NAS, and breastfeeding in the setting of maternal substance use disorders. Dr. Wachman has presented her research and numerous local and national conferences.
- Boston University School of Medicine, MD
- Georgetown University, BS
- Published on 11/13/2018
Rose-Jacobs R, Trevino-Talbot M, Lloyd-Travaglini C, Cabral HJ, Vibbert M, Saia K, Wachman EM. Could prenatal food insecurity influence neonatal abstinence syndrome severity? Addiction. 2018 Nov 13. PMID: 30422365.
- Published on 11/6/2018
Howard MB, Wachman E, Levesque EM, Schiff DM, Kistin CJ, Parker MG. The Joys and Frustrations of Breastfeeding and Rooming-In Among Mothers With Opioid Use Disorder: A Qualitative Study. Hosp Pediatr. 2018 Nov 06. PMID: 30401783.
- Published on 10/16/2018
Jones HE, Kaltenbach K, Benjamin T, Wachman EM, O'Grady KE. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions. J Addict Med. 2018 Oct 16. PMID: 30334926.
- Published on 9/1/2018
Wachman EM, Warden AH, Thomas Z, Thomas-Lewis JA, Shrestha H, Nikita FNU, Shaw D, Saia K, Schiff DM. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity. Drug Alcohol Depend. 2018 Nov 01; 192:45-50. PMID: 30205307.
- Published on 8/28/2018
Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J Pediatr. 2018 Dec; 203:34-40.e1. PMID: 30170857.
- Published on 8/1/2018
Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, Marro P, Oliveira EL, Harvey-Wilkes K, Czynski A, Engelhardt B, D'Apolito K, Bogen D, Lester B. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial. JAMA Pediatr. 2018 Aug 01; 172(8):741-748. PMID: 29913015.
- Published on 5/8/2018
Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, Saia K, Nikita F, Khattab A, Nolin A, Alvarez C, Barry K, Combs G, Stickney D, Driscoll J, Humphreys R, Burke J, Farrell C, Shrestha H, Whalen BL. Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. J Perinatol. 2018 Aug; 38(8):1114-1122. PMID: 29740196.
- Published on 4/19/2018
Wachman EM, Hayes MJ, Shrestha H, Nikita FNU, Nolin A, Hoyo L, Daigle K, Jones HE, Nielsen DA. Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads. Genes Brain Behav. 2018 09; 17(7):e12476. PMID: 29575474.
- Published on 4/9/2018
Schiff DM, Wachman EM, Philipp B, Joseph K, Shrestha H, Taveras EM, Parker MGK. Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads. Breastfeed Med. 2018 05; 13(4):266-274. PMID: 29630387.
- Published on 4/3/2018
Wachman EM, Schiff DM, Silverstein M. Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018 Apr 03; 319(13):1362-1374. PMID: 29614184.
View 17 more publications: View full profile at BUMC